IL-21-mediated non-canonical pathway for IL-1β production in conventional dendritic cells

Nature Communications

Volumn 6, Issue , 2015, Pages

  Wan, Chi Keung ^a   Li, Peng ^a   Spolski, Rosanne ^a   Oh, Jangsuk ^a   Andraski, Allison B ^a,c   Du, Ning ^a   Yu, Zu Xi ^a   Dillon, Christopher P ^b   Green, Douglas R ^b   Leonard, Warren J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; HISTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 21; SERINE PROTEINASE; STAT3 PROTEIN; CD1 ANTIGEN; CD1C PROTEIN, HUMAN; GLYCOPROTEIN; INTERLEUKIN DERIVATIVE; NIMA INTERACTING PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE; PIN1 PROTEIN, HUMAN; PIN1 PROTEIN, MOUSE; STAT3 PROTEIN, HUMAN; STAT3 PROTEIN, MOUSE;

CELLS AND CELL COMPONENTS; ENZYME; GENE EXPRESSION; INFECTIOUS DISEASE; PATHOGEN; PNEUMONIA; PROTEIN; RODENT; VIRAL DISEASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME ACTIVATION; FEMALE; MALE; MOUSE; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; BONE MARROW CELL; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HUMAN; INBRED MOUSE STRAIN; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; SPLEEN;

MURINE PNEUMONIA VIRUS;

ANIMALS; ANTIGENS, CD1; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; INTERLEUKIN-1BETA; INTERLEUKINS; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; NIMA-INTERACTING PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE; SPLEEN; STAT3 TRANSCRIPTION FACTOR;

EID: 84939145953     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8988     Document Type: Article

References (38)

1. van de Veerdonk, F. L., Netea, M. G., Dinarello, C. A. & Joosten, L. A. Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends. Immunol. 32, 110-116 (2011).
2. Dinarello, C. A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519-550 (2009).
3. Gabay, C., Lamacchia, C. & Palmer, G. IL-1 pathways in inflammation and human diseases. Nature reviews Rheumatology 6, 232-241 (2010).
4. Chung, Y. et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30, 576-587 (2009).
5. Iwakura, Y., Nakae, S., Saijo, S. & Ishigame, H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol. Rev. 226, 57-79 (2008).
6. Masters, S. L., Latz, E. & O'Neill, L. A. The inflammasome in atherosclerosis and type 2 diabetes. Sci Transl Med 3, 81ps17 (2011).
7. Dinarello, C. A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117, 3720-3732 (2011).
8. Latz, E., Xiao, T. S. & Stutz, A. Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13, 397-411 (2013).
9. Gringhuis, S. I. et al. Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1beta via a noncanonical caspase-8 inflammasome. Nat. Immunol. 13, 246-254 (2012).
10. Ozaki, K. et al. A critical role for IL-21 in regulating immunoglobulin production. Science 298, 1630-1634 (2002).
11. Ozaki, K. et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J. Immunol. 173, 5361-5371 (2004).
12. Spolski, R. & Leonard, W. J. Interleukin-21: a double-edged sword with therapeutic potential. Nat. Rev. Drug. Discov. 13, 379-395 (2014).
13. Wang, G. et al. In vivo antitumor activity of interleukin 21 mediated by natural killer cells. Cancer. Res. 63, 9016-9022 (2003).
14. Zeng, R. et al. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J. Exp. Med. 201, 139-148 (2005).
15. Brandt, K., Bulfone-Paus, S., Foster, D. C. & Ruckert, R. Interleukin-21 inhibits dendritic cell activation and maturation. Blood 102, 4090-4098 (2003).
16. Wan, C. K. et al. The cytokines IL-21 and GM-CSF have opposing regulatory roles in the apoptosis of conventional dendritic cells. Immunity 38, 514-527 (2013).
17. Hideshima, T. et al. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo. Clin. Cancer. Res. 12, 5887-5894 (2006).
18. Merad, M. & Manz, M. G. Dendritic cell homeostasis. Blood 113, 3418-3427 (2009).
19. Iyer, S. S. & Cheng, G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit. Rev. Immunol. 32, 23-63 (2012).
20. Rada-Iglesias, A. et al. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470, 279-283 (2011).
21. Shlyueva, D., Stampfel, G. & Stark, A. Transcriptional enhancers: from properties to genome-wide predictions. Nat. Rev. Genet. 15, 272-286 (2014).
22. Bernstein, B. E. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315-326 (2006).
23. Shortman, K. & Naik, S. H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7, 19-30 (2007).
24. Oberst, A. et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471, 363-367 (2011).
25. Coeshott, C. et al. Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc. Natl Acad. Sci. USA 96, 6261-6266 (1999).
26. Harper, J. W., Hemmi, K. & Powers, J. C. Reaction of serine proteases with substituted isocoumarins: discovery of 3,4-dichloroisocoumarin, a new general mechanism based serine protease inhibitor. Biochemistry 24, 1831-1841 (1985).
27. Spolski, R. et al. IL-21 promotes the pathologic immune response to pneumovirus infection. J. Immunol. 188, 1924-1932 (2012).
28. Mildner, A. & Jung, S. Development and function of dendritic cell subsets. Immunity 40, 642-656 (2014).
29. Merad, M., Sathe, P., Helft, J., Miller, J. & Mortha, A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31, 563-604 (2013).
30. Vahedi, G. et al. STATs shape the active enhancer landscape of T cell populations. Cell 151, 981-993 (2012).
31. Joosten, L. A. et al. Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta. Arthritis. Rheum. 60, 3651-3662 (2009).
32. Kuida, K. et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267, 2000-2003 (1995).
33. Mariathasan, S. et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232 (2006).
34. Mariathasan, S. et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213-218 (2004).
35. Domachowske, J. B. et al. The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection. J. Immunol. 165, 2677-2682 (2000).
36. Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome. Biol. 10, R25 (2009).
37. Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome. Biol. 9, R137 (2008).
38. Ye, T. et al. seqMINER: an integrated ChIP-seq data interpretation platform. Nucleic. Acids. Res. 39, e35 (2011).